Coronaviruses
BioNTech Aims to Develop mRNA Vaccine Against Malaria
Pharmaceutical company BioNTech is working on a new vaccine to target malaria, leveraging the mRNA technology behind its successful coronavirus vaccine. The company plans to start clinical trials for a "safe and highly effective malaria vaccine" by the end of next year. In addition to developing a malaria